Needham & Company raised its price target on HealthStream (NASDAQ: HSTM) to $32.00 (from $28.00) while maintaining a Buy rating, following first quarter results and earnings call.

Analyst Scott Berg notes management's earnings call focused on improving sales from the Workforce Solutions segment, while the company remains poised to deliver higher operating margins in 2018, as customers adopt new products driving incremental margin leverage.